A hand written registry book of the department of haematology, Dhaka Medical College & Hospital was kept from the year of its establishment of independent working, 2005. However, the data of 2005 was not included here as it was partial. The entry was done by the haematologists who signed the report. It is common practice to consult with fellow colleagues before finalizing the report. From 2006 to 2009 all the entries were included in this study. There was possibility that some cases were not included into the registry. Cases of aspiration failures were also rarely included in the registry and thus were not included in this study. Patients were from the department of haematology and all other department including both adult and paediatrics. Bone marrow reports made here is based on morphology only with leishmen's stain. Few doubtful cases were further validated with further investigation. Data was analyzed in Microsoft Excel, and presented with tables and graphs. No ethical issue is raised here as data was collected from medical records kept for departmental activities in a public medical college hospital and it does not reveal any personal information which may cause any harm to any subject.
Results:
A total of 2340 bone marrow reports were included in this study. The prevalence of disease is shown in the Fig 1. This number does not include the aspiration failure cases. The bar chart shows acute leukaemia is the most common disease with 1022 cases in total where ALL is the most prevalent disease with 520 cases closely followed by AML 502 cases.
In Table I , the disease prevalence shown by year. The total numbers of reported cases are 377, 527, 712 and 724 for years from 2006 to 2009 respectively. Although the number of total cases in ALL is slightly more than the AML (520 vs. 502) the reverse is true in case of new cases which represent the actual incidence (334 for AML and 284 for ALL). In case of leukemia and multiple myeloma new and old cases is reported separately. Erythroid and myeloid hyperplasia marrow are grouped under reactive marrow. Rare diseases like histoplasmosis, plasma cell leukaemia, pure red cell aplasia etc are grouped under other category.
The percentage of new and old cases in acute leukaemia is further detailed in Fig 2 by a pie diagram (Fig 2) . Acute leukaemia is the leading disease (43.67%) from a haematology ward as expected. The curious finding is that the new case of AML is more than the ALL (331vs 282) but reverse in the total cases (520 vs. 502). Also old cases are less than the new cases (ALL new cases 28% vs. ALL old cases 23% and AML new cases 33% vs. AML old cases 16%) This is because poor socio economic conditions often force the haematologist and the family to go for palliative treatment especially in case of AML. So, in many cases after diagnosis further bone marrow was not required. Only exception is ALL data for 2009 where the old cases were more than the new cases. This indicates the improved survival of the ALL patient in this center. Also as bone marrow examination with old patient with palliative option is not absolute, may be many poor patients included in this study may not need this invasive procedure. 3 Reactive marrow report and normal active marrow (21.15%) was quite high having the position just after leukaemia. The reason behind it is multiple. NHL stage I and II were the commonest cause. But a large number of cases might not have proper indication for bone marrow. Referral for bone marrow with any kind of cytopenia (i.e. autoimmune haemolytic anaemia) was an example for that. Also there might be cases of MDS-refractory anaemia in this reports as iron stain was not done. Proper referral and further investigation might reduce and change this diagnosis to a significant number.
Megakaryocytic hyperplasia is another interesting finding of this study (7.61%). Though the clinical indication did not recorded but to the author's experience most of them referred for the confirmation of the diagnosis of ITP. Though it is 
Discussion
The increasing number of cases year by year indicated that the bone marrow is a reliable and valid tool for diagnosis in this center. One of the unusual reason for this is, bone marrow examination was often requested or preformed before other now established that bone marrow is not needed for the diagnosis of ITP. 4 The trend is declining for the year of 2009 and may decrease further in coming years as the department tries to refuse such kind of referral.
In CML cytogenic study for Philadelphia chromosome was carried out on bone marrow sample. But many patients who could not afford imatinib mesylate and thus were not gone under bone marrow examination. So, the actual number of CML was few more than the number represents here.
Conclusion
Bone marrow examination is an important diagnostic tool for diagnosis of the haematological and non-haematological diseases. But indication for the examination and the validation of this bone marrow report by further investigation is not optimum. Limitations of this diagnostic tool should be supplemented with other investigations.
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